| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 153.1 | 161.2 | 154.5 |
| Other income | 3.0 | 1.6 | 13.6 |
| Total income | 156.0 | 162.9 | 168.0 |
| Profit before exceptional items & tax | 12.4 | 19.2 | 11.7 |
| Exceptional items | -33.2 | 0.0 | 0.0 |
| Profit before tax | -20.8 | 19.2 | 11.7 |
| Net profit | -22.9 | 15.7 | 11.2 |
| Operating margin | -13.3% | 11.8% | 7.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -0.90% |
|---|
NSE results filing, NSE: BAJAJHCARE. Figures extracted from the filing.
Bajaj Healthcare Ltd: key numbers
- Share price
- ₹344.15
- Market cap
- ₹1,159 Cr
- Revenue (annual)
- ₹611.0 Cr
- Net profit (annual)
- ₹15.77 Cr
- P/E (TTM)
- 65.7×Sector 50.4×
- Promoter holding
- 58.59%+0.30% QoQ
- FII holding
- 2.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Healthcare Ltd
All →Bajaj Healthcare Annual General Meeting
Bajaj Healthcare Limited concluded its 33rd Annual General Meeting on September 21, 2026. The shareholders transacted ordinary and special business, including a final dividend declaration.
Bajaj Healthcare Dividend
Bajaj Healthcare Limited has fixed September 14, 2026, as the record date for a 30% final dividend. The dividend of ₹1.50 per share awaits shareholder approval.
Bajaj Healthcare Investor Presentation: Key Takeaways
Q1FY27 revenue grew 11.3% YoY to INR 165.6 Cr with PAT at INR 13.9 Cr. Focus shifting toward high-margin peptides, oncology APIs, and specialized formulations.
- Call
- Guides 12% growth
Bajaj Healthcare Earnings Call Transcript: Key Takeaways
Bajaj Healthcare is pivoting from high-volume commodities to high-margin specialized APIs and formulations, targeting a ₹1000 Cr topline via new oncology and peptide capacities.
- Call
- Guides 15% growth
Bajaj Healthcare Q1 FY27 Results: Net Profit ₹13.7 Cr, Up 16.1% YoY
Bajaj Healthcare Ltd reported revenue from operations of ₹165.6 Cr (+11.3% YoY) and net profit of ₹13.7 Cr (+16.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹13.7 Cr · +16.1% YoY